Global HIV Diagnostics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 3615

The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.
In 2018, the global HIV Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global HIV Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Diagnostics development in United States, Europe and China.

The key players covered in this study
Alere Inc.
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux

Market segment by Type, the product can be split into
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services

Market segment by Application, split into
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HIV Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the HIV Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HIV Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HIV Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Consumables
1.4.3 Assay, Kits and Reagents
1.4.4 Other Consumables
1.4.5 Instruments
1.4.6 Software and Services
1.5 Market by Application
1.5.1 Global HIV Diagnostics Market Share by Application (2014-2025)
1.5.2 Antibody Tests
1.5.3 Viral Load Tests
1.5.4 CD4 Tests
1.5.5 Tests for Early Infant Diagnosis
1.5.6 Tests for Viral Identification
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 HIV Diagnostics Market Size
2.2 HIV Diagnostics Growth Trends by Regions
2.2.1 HIV Diagnostics Market Size by Regions (2014-2025)
2.2.2 HIV Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 HIV Diagnostics Market Size by Manufacturers
3.1.1 Global HIV Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global HIV Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 HIV Diagnostics Key Players Head office and Area Served
3.3 Key Players HIV Diagnostics Product/Solution/Service
3.4 Date of Enter into HIV Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global HIV Diagnostics Market Size by Type (2014-2019)
4.2 Global HIV Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States HIV Diagnostics Market Size (2014-2019)
5.2 HIV Diagnostics Key Players in United States
5.3 United States HIV Diagnostics Market Size by Type
5.4 United States HIV Diagnostics Market Size by Application

6 Europe
6.1 Europe HIV Diagnostics Market Size (2014-2019)
6.2 HIV Diagnostics Key Players in Europe
6.3 Europe HIV Diagnostics Market Size by Type
6.4 Europe HIV Diagnostics Market Size by Application

7 China
7.1 China HIV Diagnostics Market Size (2014-2019)
7.2 HIV Diagnostics Key Players in China
7.3 China HIV Diagnostics Market Size by Type
7.4 China HIV Diagnostics Market Size by Application

8 Japan
8.1 Japan HIV Diagnostics Market Size (2014-2019)
8.2 HIV Diagnostics Key Players in Japan
8.3 Japan HIV Diagnostics Market Size by Type
8.4 Japan HIV Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia HIV Diagnostics Market Size (2014-2019)
9.2 HIV Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia HIV Diagnostics Market Size by Type
9.4 Southeast Asia HIV Diagnostics Market Size by Application

10 India
10.1 India HIV Diagnostics Market Size (2014-2019)
10.2 HIV Diagnostics Key Players in India
10.3 India HIV Diagnostics Market Size by Type
10.4 India HIV Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America HIV Diagnostics Market Size (2014-2019)
11.2 HIV Diagnostics Key Players in Central & South America
11.3 Central & South America HIV Diagnostics Market Size by Type
11.4 Central & South America HIV Diagnostics Market Size by Application

12 International Players Profiles
12.1 Alere Inc.
12.1.1 Alere Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 HIV Diagnostics Introduction
12.1.4 Alere Inc. Revenue in HIV Diagnostics Business (2014-2019)
12.1.5 Alere Inc. Recent Development
12.2 Abbott Healthcare
12.2.1 Abbott Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 HIV Diagnostics Introduction
12.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2014-2019)
12.2.5 Abbott Healthcare Recent Development
12.3 Abbvie Inc.
12.3.1 Abbvie Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 HIV Diagnostics Introduction
12.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2014-2019)
12.3.5 Abbvie Inc. Recent Development
12.4 Brsitol-Myers Squibb
12.4.1 Brsitol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 HIV Diagnostics Introduction
12.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2014-2019)
12.4.5 Brsitol-Myers Squibb Recent Development
12.5 Janssen Therapeutics
12.5.1 Janssen Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 HIV Diagnostics Introduction
12.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2014-2019)
12.5.5 Janssen Therapeutics Recent Development
12.6 Gilead Sciences
12.6.1 Gilead Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 HIV Diagnostics Introduction
12.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2014-2019)
12.6.5 Gilead Sciences Recent Development
12.7 Merck & Co. Inc
12.7.1 Merck & Co. Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 HIV Diagnostics Introduction
12.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2014-2019)
12.7.5 Merck & Co. Inc Recent Development
12.8 VIIV Healthcare
12.8.1 VIIV Healthcare Company Details
12.8.2 Company Description and Business Overview
12.8.3 HIV Diagnostics Introduction
12.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2014-2019)
12.8.5 VIIV Healthcare Recent Development
12.9 BD Biosciences
12.9.1 BD Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 HIV Diagnostics Introduction
12.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2014-2019)
12.9.5 BD Biosciences Recent Development
12.10 Beckman Coulter
12.10.1 Beckman Coulter Company Details
12.10.2 Company Description and Business Overview
12.10.3 HIV Diagnostics Introduction
12.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2014-2019)
12.10.5 Beckman Coulter Recent Development
12.11 Partec
12.12 Sysmex
12.13 Apogee Flow Systems
12.14 PointCare Technologies Inc.
12.15 Zyomyx Inc.
12.16 Mylan inc.
12.17 Roche Diagnostics
12.18 Siemens Healthcare
12.19 Qiagen
12.20 BioMerieux

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details